FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved a supplemental application for oxybutynin chloride from Lannett Company, expanding the availability of a generic formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Detrusor Overactivity
• Overactive Bladder
• Urge Urinary Incontinence

Drugs mentioned

• Oxybutynin chloride (Oxybutynin chloride)

Snippet

SUPPL AP for OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)